WealthShield Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.79M Sell
3,032
-90
-3% -$91.2K 0.31% 89
2025
Q4
$3.36M Sell
3,122
-43
-1% -$41.1K 0.37% 72
2025
Q3
$2.41M Sell
3,165
-70
-2% -$52.1K 0.27% 98
2025
Q2
$2.52M Sell
3,235
-52
-2% -$40.4K 0.3% 93
2025
Q1
$2.71M Buy
3,287
+306
+10% +$255K 0.35% 86
2024
Q4
$2.3M Sell
2,981
-677
-19% -$561K 0.33% 89
2024
Q3
$3.24M Sell
3,658
-146
-4% -$131K 0.44% 65
2024
Q2
$3.44M Buy
3,804
+339
+10% +$271K 0.52% 51
2024
Q1
$2.7M Sell
3,465
-770
-18% -$548K 0.44% 68
2023
Q4
$2.47M Buy
4,235
+2,168
+105% +$1.27M 0.41% 70
2023
Q3
$1.11M Buy
2,067
+1,186
+135% +$611K 0.17% 137
2023
Q2
$413K Buy
881
+210
+31% +$88.1K 0.06% 218
2023
Q1
$230K Hold
671
0.04% 279
2022
Q4
$245K Buy
671
+18
+3% +$6.38K 0.05% 261
2022
Q3
$211K Sell
653
-5
-0.8% -$1.58K 0.04% 280
2022
Q2
$213K Buy
+658
New +$198K 0.04% 279
2022
Q1
Sell
-1,003
Closed -$277K 359
2021
Q4
$277K Buy
+1,003
New +$254K 0.05% 242
2021
Q3
Sell
-284
Closed -$65K 512
2021
Q2
$65K Hold
284
0.01% 425
2021
Q1
$53K Sell
284
-1,381
-83% -$270K 0.01% 447
2020
Q4
$281K Buy
1,665
+29
+2% +$4.33K 0.05% 241
2020
Q3
$242K Sell
1,636
-13
-0.8% -$2.01K 0.08% 222
2020
Q2
$271K Buy
+1,649
New +$253K 0.12% 161

Other funds holding LLY

WealthShield Partners's LLY Position: Q1 2026 in Review

WealthShield Partners reduced its Eli Lilly (LLY) stake by 2.9% in Q1 2026, selling an estimated $91.2K and leaving 3,032 shares worth $2.79M. The position accounts for 0.31% of the portfolio, ranked #89.

WealthShield Partners first reported a position in LLY in Q2 2020 and has held it in 22 quarters since. The position peaked at $3.44M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • WealthShield Partners held 3,032 shares of Eli Lilly worth $2.79M as of Q1 2026.
  • WealthShield Partners sold 90 Eli Lilly shares in Q1 2026, an estimated $91.2K.
  • Eli Lilly made up 0.31% of WealthShield Partners's portfolio in Q1 2026, its #89 holding.
  • WealthShield Partners first reported a position in Eli Lilly in Q2 2020 and has held it in 22 quarters since.
  • WealthShield Partners's Eli Lilly position peaked at $3.44M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.